Parataxis Korea, Inc.

₩416.00As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:288330Healthcare
Country South Korea
PE (Fwd) •••
TSR 7Y CAGR (40.06%)
Div yield —
ROE (81.82%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 1.63
PE TTM —
TSR TTM (68.86%)
Mkt cap ₩44.13B
ROIC (17.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩439
5.57%
(48.29%)
Hold 2|9|5|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
5.70
6.27
6.59
6.48
11.31%
28.48%
28.88%
15.94%
Revenue₩B
2.534
2.539
2.524
2.590
17.08%
18.24%
11.61%
8.28%
Peers (US$32.53M)
Cap (US$)
PE
33.07M
7.715x
33.02M
—
30.91M
—
Capital
TTM
5Y
10Y
Leveragex
1.306
0.190
0.169
EBIT/Intx
0.746
0.555
0.436
Own earn%
(116.16)
(118.77)
(112.14)
Sh yield%
34.61
11.51
11.47
Owners
Insiders/Inst%
9.41
75.17
Short interest%
3.34
SBC / revenue%
5.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
23–27
$1 testx
0.0
Incr. ROIC%
13